bluuebunny/crossref_metadata_2025_split huggingface dataset:
Crystal structure of diaqua-di(2-methoxyacetato)copper(II), C6H14CuO8
Authors: Zhu H.-L. , Zeng Q.-F. , Xia D.-S. , Zhu X.-L. , Liu X. , Wang D.-Q. 
Published: September 2014

AbstractC6H14CuO8, monoclinic, P121/n1 (No. 14), a = 6.955(1) Å, b = 10.123(2) Å, c = 7.226(1) Å, β = 96.57(1)°, V = 505.4 Å3, Z = 2, Rgt(F) = 0.026, wRref(F2) = 0.069, T = 292 K.
Crystal structure of tetra-n-butylammonium (1,3-dithiol-2-thione-4,5-dithiolato)-( diethyldithiocarbamato-S,S')-nickelate(II), (C16H36N)(C8H10NNiS7)
Authors: Xu W. , Fang Q. , Xue G. , Yu W.-T. 
Published: September 2014

AbstractC24H46N2NiS7, monoclinic, C1c1 (No. 9), a = 8.846(2) Å, b = 24.702(6) Å, c = 15.392(3) Å, β = 95.12(1)°, V = 3349.9Å3, Z = 4, Rgt(F) = 0.059, wRref(F2) = 0.166, T = 293 K.
Crystal structure of diaqua-(2-carboxyethylene-8-hydroxyquinolinato)- copper(II) monohydrate, Cu(C12H9O3N)(H2O)2 · H2O
Authors: Tanaka J.-I. , Itoh K. , Setsune J.-I. 
Published: September 2014

AbstractC12H15CuNO6, triclinic, P1̅ (No. 2), a = 7.363(2) Å, b = 8.985(2) Å, c = 10.349(2) Å, α = 97.438(4)°, β = 100.846(4)°, ϒ = 106.334(4)°, V = 633.1 Å3, Z = 2, Rgt(F) = 0.029, wRobs(F2) = 0.073, T = 298 K
Crystal structure of pimolin, C26H20O8
Authors: Pal A. , Pradhan P. , Banerji A. , Singh T. P. 
Published: September 2014

AbstractC26H20O8, triclinic, P̅1̅ (No. 2), a = 9.002(2) Å, b = 9.140(2) Å, c = 14.501(3) Å, α = 104.90(3)°, β = 95.34(3)°, ϒ = 113.83(3)°, V = 1028.2Å3, Z = 2, Rgt(F) = 0.074, wRref(F2) = 0.250, T = 293 K.
Crystal structure of trans-diaqua-di(bis(pyrazolylmethane)copper(II) dinitrate, Cu(C7H10N4)2(OH2)2(NO3)2
Authors: Van Langenberg K. A. , Moubaraki B. , Murray K. S. , Tiekink E. R. T. 
Published: September 2014

AbstractC14H20CuN10O8, triclinic, P1̅ (No. 2), a = 8.498(1) Å, b = 9.167(2) Å, c = 8.323(3) Å, α = 103.41(3)°, β = 101.87(3)°, ϒ = 117.10(1)°, V = 523.9 Å3, Z = 1, Rgt(F) = 0.041, wRref(F2) = 0.122, T = 293 K.
Crystal structure of bis(2,6-diaminopyridinium) diaqua-bis-(2,6-pyridinedicarboxylato)-bis(2,6-pyridinedicarboxylato)- dibismuthate(III) tetrahydrate, (C28H16O18N4Bi2)(C5H8N3)2 · 4H2O
Authors: Ranjbar M. , Aghabozorg H. , Moghimi A. 
Published: September 2014

Abstract C38H40Bi2N10O22, triclinic, P1̅̅ (No. 2), a = 9.699(1) Å, b = 10.500(1) Å, c = 10.890(1) Å, α = 85.587(3)°, β = 88.128(3)°, γ = 84.257(3)°, V = 1099.9 Å3, Z = 1, Rgt(F) = 0.028, wRref(F2) = 0.061, T = 295 K.
Crystal structure of 2,2′-bis(4,5-dimethylimidazole)(dithiocyanato)mercury(II), Hg(C10H14N4)(CNS)2
Authors: Mahjoub A. R. , Ramazani A. , Morsali A. 
Published: September 2014

Abstract C12H14HgN6S2, triclinic, P1̅̅̅ (No. 2), a = 7.732(2) Å, b = 10.252(2) Å, c = 11.802(2) Å, α = 65.57(3)°, β = 72.19(3)°, γ = 88.13(3)°, V = 806.2 Å3, Z = 2, Rgt(F) = 0.048, wR*(F2) = 0.123, T = 293 K.
Crystal structure of di(2,2′-bipyridine)tetra[μ-(4-methylbenzoato-O,O′)]- di(4-methylbenzoato)disamarium(III), Sm2(C8H7O2)6(C10H8N2)2
Authors: Li X. , Zou Y.-Q. 
Published: September 2014

Abstract C68H58N4O12Sm2, monoclinic, C12/c1 (No. 15), a = 14.123(7) Å, b = 19.151(9) Å, c = 23.12(1) Å, β = 96.600(8)°, V = 6211.0 Å3, Z = 4, Rgt(F) = 0.029, wRref(F2) = 0.053, T = 293 K.
Crystal structure of 4-aminopyrimidine, C4H5N3
Authors: Van Meervelt L. , Uytterhoeven K. 
Published: September 2014

Abstract C4H5N3, orthorhombic, Pcab (No. 61), a = 10.983(2) Å, b = 12.287(3) Å, c = 14.052(3) Å, V = 1896.3 Å3, Z = 16, Rgt(F) = 0.054, wRref(F2) = 0.146, T = 289 K.
Crystal structure of 1-[(4-chloro-phenyl)-phenyl-methyl]piperazine, C17H19ClN2
Authors: Hu X.-R. , Gu J.-M. , Lu G.-L. 
Published: September 2014

Abstract C17H19ClN2, orthorhombic, P212121 (No. 19), a = 18.0920(1) Å, b = 5.8896(1) Å, c = 14.6011(2) Å, V = 1555.8 Å3, Z = 4, Rgt(F) = 0.048, wRref(F2) = 0.114, T = 298 K.
Crystal structure of diaqua-trans-dicinnamato-dihexamethylenetetraminecobalt(II) dihydrate, Co(C6H12N4)2(C9H7O2)2(H2O)2 · 2H2O
Authors: Zhu H.-L. , Shao S.-C. , Qiu X.-Y. , Sun L. , Yang S. , Ma J.-L. 
Published: September 2014

Abstract C30H46CoN8O8, monoclinic, P121/c1 (No. 14), a = 12.779(3) Å, b = 10.938(2) Å, c = 12.218(2) Å, β = 97.56(3)°, V = 1693.0 Å3, Z = 2, Rgt(F) = 0.085, wRref(F2) = 0.201, T = 293 K.
Crystal structure of triaquasulfato-2,3-diaza-1,6-di(4-fluorobenzyl)-hexanecopper(II) dihydrate, Cu(C16H18N2F2)(H2O)3(SO4) · 2H2O
Authors: Zhu H.-L. , Qiu X.-Y. , Yang S. , Ma J.-L. 
Published: September 2014

Abstract C16H28CuF2N2O9S, monoclinic, P121/c1 (No. 14), a = 15.169(8) Å, b = 12.614(6) Å, c = 11.387(6) Å, β = 94.651(7)°, V = 2171.6 Å3, Z = 4, Rgt(F) = 0.046, wRref(F2) = 0.138, T = 298 K.
Crystal structure of 1,3,5-trimethyl-6-phenyl-2,4-dioxohexahydro-1,3,5-triazine, C12H15N3O2
Authors: Klepp K. O. , Schmidt H. 
Published: September 2014

Abstract C12H15N3O2, monoclinic, P121/n1 (No. 14), a = 8.902(6) Å, b = 12.674(2) Å, c = 10.647(4) Å, β = 98.84(2)°, V = 1187.0 Å3, Z = 4, Rgt(F) = 0.048, wRobs(F) = 0.048, T = 294 K.
Crystal structure of the adduct of sulfosalicylic acid and thiourea, C7H6O6S · CH4N2S
Authors: Xiong J. , Hu M.-L. , Shi Q. , Xiao H.-P. 
Published: September 2014

Abstract C8H10N2O6S2, monoclinic, P121/n1 (No. 14), a = 7.6806(5) Å, b = 12.8546(8) Å, c = 12.2389(7) Å, β = 97.071(2)°, V = 1199.2 Å3, Z = 4, Rgt(F) = 0.035, wRref(F2) = 0.099, T = 273 K.
Crystal structure of diaqua-bis(pyridine)-μ2-squarato(1,3)cobalt(II), Co(C4O4)(C5H5N)2(H2O)2
Authors: Kirchmaier R. , Altin E. , Lentz A. 
Published: September 2014

Abstract C14H14N2CoO6, orthorhombic, Pbca (no. 61), a = 11.325(2) Å,b = 7.959(1) Å, c = 16.664(3) Å, V = 1502.0 Å3, Z = 4, Rgt(F) = 0.023, wRref(F2) = 0.060, T = 293 K.
Crystal structures of acetonitrile solvates of bis(tetraphenylphosphonium) tetrachlorooxovanadate(IV), hexachlorostannate(IV) and -molybdate(IV), [P(C6H5)4]2[VOCl4] · 4CH3CN, [P(C6H5)4]2[MCl6] · 4CH3CN (M = Sn, Mo)
Authors: Rabe Susanne , Bubenheim Wilfried , Müller Ulrich 
Published: September 2014

Abstract C56H52Cl4N4OP2V, monoclinic, P121/c1 (no. 14), a = 9.473(2) Å, b = 19.832(6) Å, c = 14.461(2) Å, β = 99.00(2)°, V = 2683.3 Å3, Z = 2, Rgt(F) = 0.035, wRref(F2) = 0.096, T = 193 K.C56H52Cl6N4P2Sn, monoclinic, P121/c1 (no. 14), a = 9.606(7) Å, b = 19.842(9) Å, c = 15.129(9) Å, β = 98.91(2)°, V = 2848.8 Å3, Z = 2, Rgt(F) = 0.038, wRref(F2) = 0.089, T = 300 K.C56H52Cl6MoN4P2, monoclinic, P121/c1 (no. 14), a = 9.505(3) Å, b = 19.624(2) Å, c = 14.759(2) Å, β = 98.72(2)°, V = 2721.1 Å3, Z = 2, Rgt(F) = 0.062, wRref(F2) = 0.175, T = 193 K.
Crystal structure of 3-diphenylamino-benzo[de]anthracen-7-one, C29H19NO
Authors: Yu M.-X. 
Published: September 2014

Abstract C29H19NO, monoclinic, P121/c1 (no. 14), a = 23.218(4) Å, b = 14.748(2) Å, c = 12.094(2) Å, β = 90.986(4)°, V = 4140.6 Å3, Z = 8, Rgt(F) = 0.045, wRref(F2) = 0.085, T = 293 K.
Crystal structure of tetraaqua-bis(pyridine-2,6-dicarboxylato-O,N,O′)- (μ2-pyrazino)dinickel(II), [Ni2(C4H4N2)(C7H3NO4)2(H2O)4]
Authors: Altin E. , Kirchmaier R. , Lentz A. 
Published: September 2014

Abstract C18H18N4Ni2O12, monoclinic, P121/c1 (no. 14), a = 7.558(2) Å, b = 20.004(3) Å, c = 7.135(2) Å, β = 92.02(3)°, V = 1078.1 Å3, Z = 2, Rgt(F) = 0.023, wRref(F2) = 0.061, T = 293 K.
Crystal structure of 2,3-bis(2-cyanoethylthio)-6,7-vinylenedithiotetrathiafulvalene, C14H10N2S8
Authors: Xue G. , Yu W.-T. , Fang Q. 
Published: September 2014

Abstract C14H10N2S8, triclinic, P1̅ (no. 2), a = 7.753(2) Å, b = 11.403(3) Å, c = 12.371(5) Å, α = 64.10(2)°, β = 84.62(2)°, γ = 77.34(2)°, V = 959.9 Å3, Z = 2, Rgt(F) = 0.061, wRref(F2) = 0.168, T = 293 K.
Crystal structure of dipotassium octakis(μ3-bromo)hexabromo-octahedrohexamolybdenate, K2[Mo6Br14]
Authors: Xu W. , Wang P. , Zheng Y.-Q. 
Published: September 2014

Abstract Br14K2Mo6, cubic,Pn3̅ (no. 201), a = 13.800(2) Å, V = 2628.1Å3, Z = 4, Rgt(F) = 0.077, wRref(F2) = 0.186, T = 293 K.
Crystal structures of (barium, europium) platinum trigermanium, Ba1-xEuxPtGe3 (x = 0, 0.27, 1)
Authors: Demchyna R. , Prots Yu. , Schnelle W. , Burkhardt U. , Schwarz U. 
Published: September 2014

Abstract BaGe3Pt, tetragonal, I4mm (no. 107), a = 4.5636(2) Å, c = 10.2341(6) Å, V = 213.1 Å3, Z = 2, Rgt(F) = 0.030, wRref(F2) = 0.074, T = 293 K. Ba0.73Eu0.27Ge3Pt, tetragonal, I4mm (no. 107), a = 4.5432(1) Å, c = 10.1763(2) Å, V = 210.0 Å3, Z = 2, Rgt(F) = 0.025, wRref(F2) = 0.061, T = 293 K. EuGe3Pt, tetragonal, I4mm (no. 107), a = 4.4633(1) Å, c = 10.0625(4) Å, V = 200.5 Å3, Z = 2, Rgt(F) = 0.018, wRref(F2) = 0.035, T = 293 K.
Crystal structure of μ3-chloro-μ3-hydroxo-tris(μ-chloro)tris(tetramethylethylenediamine) trinickel(II) iodide, [Ni3(C6H16N2)3Cl4(OH)]I
Authors: Miyamoto K. , Koizumi R. , Horn E. , Fukuda Y. 
Published: September 2014

AbstractC18H49Cl4IN6Ni3O, monoclinic, C12/c1 (no. 15), a = 33.562(7) Å, b = 12.220(2) Å, c = 18.849(4) Å, β = 117.70(3)°, V = 6844.7 Å3, Z = 8, Rgt(F) = 0.059, wRref(F) = 0.066, T = 273 K.
Crystal structure of potassium trifluoro[1,3-dithiano]borate, K(C4S2H7BF3)
Authors: Stefani H. A. , Cella R. , Zukerman-Schpector J. , Caracelli I. 
Published: September 2014

AbstractC4H7BF3KS2, monoclinic, P121/c1 (no. 14), a = 14.7374(3) Å, b = 9.0612(1) Å, c = 13.5805(2) Å, β = 98.964(4)°, V = 1791.4 Å3, Z = 8, Rgt(F) = 0.029, wRref(F2) = 0.010, T = 296 K.
Crystal structure of 1,3-bis(1-phenyl-1H-tetrazol-5-ylthio)propane, C3H6(SCN4C6H5)2
Authors: Zhang G.-F. , Dou Y.-L. , She J.-B. , Zhao S.-M. , Liu H.-Q. 
Published: September 2014

AbstractC17H16N8S2, monoclinic, P121/n1 (no. 14), a = 16.716(5) Å, b = 6.492(2) Å, c = 18.640(6) Å, β = 112.126(5)°, V = 1873.8 Å3, Z = 4, Rgt(F) = 0.052, wRref(F2) = 0.128, T = 298 K.
Crystal structure of bis(1,10-phenanthroline-N,N')bis(2-chlorobenzoato) tetrakis(μ-2-chlorobenzoato)dilanthanum(III), La2(C12H8N2)2(ClC7H4O2)6
Authors: Zhang B.-S. 
Published: September 2014

AbstractC66H40Cl6La2N4O12, triclinic, P1̅ (no. 2), a = 11.9963(3) Å, b = 12.6912(3) Å, c = 21.2420(7) Å, α = 85.270(2)°, β = 73.661(2)°, ϒ = 86.307(2)°, V = 3090.0 Å3, Z = 2, Rgt(F) = 0.057, wRref(F2) = 0.155, T = 293 K.
Crystal structure of dibromo-bis(1,3-imidazolidine-2-thione-S)zinc(II), ZnBr2(C3H6N2S)2
Authors: Fettouhi M. , Wazeer M. I. M. , Isab A. A. 
Published: September 2014

AbstractC6H12Br2N4S2Zn, monoclinic, P121/n1 (no. 14), a = 8.0984(5) Å, b = 13.4094(9) Å, c = 12.3230(8) Å, β = 100.983(1)°, V = 1313.7 Å3, Z = 4, Rgt(F) = 0.031, wRref(F2) = 0.074, T = 294 K.
Crystal structure of picolinic acid hydrazide, C6H7N3O
Authors: Zareef M. , Iqbal R. , Zaidi J. H. , Qadeer G. , Wong W.-Y. , Akhtar H. 
Published: September 2014

Abstract C6H7N3O, monoclinic, C12/c1 (no. 15), a = 19.222(2) Å, b = 3.8987(4) Å, c = 18.115(2) Å, β = 107.095(2)°, V = 1297.6 Å3, Z = 8, Rgt(F) = 0.038, wRref(F2) = 0.122, T = 293 K.
Crystal structure of hexakis(μ2-acetato)-tris(acetonitrile-κN)-μ3-oxotrialuminum( III) tetrachloroaluminate, [Al3(C2H3O2)6(C2H3N)3O][AlCl4]
Authors: Lemoine P. , Bekaert A. , Brion J. D. , Viossat B. 
Published: September 2014

Abstract C18H27Al4Cl4N3O13, orthorhombic, C2221 (no. 20), a = 11.867(5) Å, b = 15.421(5) Å, c = 19.181(5) Å, V = 3510.1 Å3, Z = 4, Rgt(F) = 0.049, wRref(F2) = 0.140, T = 293 K.
Crystal structure of dichloro-bis(n-pentyl)tin(IV), Sn(C5H11)2Cl2, tin-halide compounds - part VI
Authors: Reuter H. , Izaaryene M. 
Published: September 2014

Abstract C10H22Cl2Sn, orthorhombic, P212121 (no. 19), a = 6.5566(6) Å, b = 9.068(1) Å, c = 25.316(2) Å, V = 1505.2 Å3, Z = 4, Rgt(F) = 0.062, wRref(F2) = 0.167, T = 258 K.
Crystal structure of pentapraseodymium diboropentacarbide, Pr5B2C5
Authors: Babizhetskyy V. , Mattausch Hj. , Simon A. 
Published: September 2014

Abstract B2C5Pr5, tetragonal, P4/ncc (no. 130), a = 8.448(1) Å, c = 10.970(2) Å, V = 782.9 Å3, Z = 4, Rgt(F) = 0.033, wRref(F2) = 0.063, T = 293 K.
Crystal structure of (E)-4-methoxy-nitrophenone N-(2,4-dinitrophenyl) hydrazone, C14H11N5O7
Authors: Zhao L.-F. 
Published: September 2014

Abstract C14H11N5O7, monoclinic, P121/c1 (no. 14), a = 15.075(2) Å, b = 17.683(3) Å, c = 6.099(1) Å, β = 100.43(1)°, V = 1599.0 Å3, Z = 4, Rgt(F) = 0.055, wRref(F2) = 0.175, T = 296 K.
Crystal structure of poly-[(3-hydroyxpyridine)oxalatocopper(II)] monohydrate, Cu(NC5H4OH)(COO)2 · H2O
Authors: Wiehl L. , Schreuer J. , Haussühl E. 
Published: September 2014

Abstract C7H7CuNO6, monoclinic, P121/c1 (no. 14), a = 12.9147(8) Å, b = 9.1615(6)Å, c = 8.2474(5)Å, β = 98.490(5)°, V = 965.1Å3, Z = 4, Rgt(F) = 0.031, wRref(F2) = 0.079, T = 293 K.
Crystal structure of bis(1,10-phenanthroline-N,N′)bis(4-fluorobenzoato- O,O′)tetrakis(μ-4-fluorobenzoato-O,O′)dineodymium(III), Nd2(C6H4FCOO)6(C12H8N2)2
Authors: Li X. 
Published: September 2014

Abstract C66H40F6N4Nd2O12, triclinic, P1̅ (no. 2), a = 9.799(1) Å, b = 11.858(2) Å, c = 14.627(2) Å, α = 111.031(2)°, β = 99.468(2)°, γ = 102.265(2)°, V = 1495.3 Å3, Z = 1, Rgt(F) = 0.026, wRref(F2) = 0.065, T = 293 K.
Crystal structure of 5-fluoro-1-(carboxymethyl)uracil, C6H5FN2O4
Authors: Zhang L.-J. , Ding J.-C. , Wu H.-Y. , Liu M.-C. 
Published: September 2014

Abstract C6H5FN2O4, monoclinic, P121/c1 (no. 14), a = 4.9363(5) Å, b = 17.056(2) Å, c = 9.4940(8) Å, β = 114.466(4)°, V = 727.6 Å3, Z = 4, Rgt(F) = 0.044, wRref(F2) = 0.109, T = 298 K.
Crystal structure of kakkalidone, C23H24O11
Authors: Zhang X.-Q. , Zhang Z.-T. , Zhang X.-L. 
Published: September 2014

Abstract C23H24O11, monoclinic, P1211 (no. 4), a = 6.081(3) Å, b = 7.838(3) Å, c = 22.60(1) Å, β = 92.127(7)°, V = 1076.4 Å3, Z = 2, Rgt(F) = 0.072, wRref(F2) = 0.226, T = 298 K.
Crystal structure of rel-(2R,3aS)-2-bromomethyl-3,3a,4,5,6,7-hexahydro- 2H-indole 1-oxide, C9H14BrNO
Authors: Frey W. , Gulla M. , Jäger V. 
Published: September 2014

Abstract C9H14BrNO, monoclinic, C1c1 (no. 9), a = 6.079(1) Å, b = 19.095(4) Å, c = 8.169(1) Å, β = 95.23(1)°, V = 944.2 Å3, Z = 4, Rgt(F) = 0.047, wRref(F2) = 0.120, T = 293 K.
Crystal structure of 2,2″:6′,2″-terpyridine 1,1″-dioxide 1,2,4,5-tetracyanobenzene, C15H11N3O2 · C6H4(CN)4
Authors: McKay S. E. , Wheeler K. A. , Holthouse B. 
Published: September 2014

Abstract C25H13N7O2, monoclinic, C12/c1 (no. 15), a = 24.404(3) Å, b = 6.487(1)Å, c = 13.487(2)Å, β = 108.29(1)°, V = 2027.4Å3, Z = 4, Rgt(F) = 0.038, wRref(F2) = 0.099, T = 173 K.
Copeptin concentrations during psychological stress: the PsyCo study
Authors: Siegenthaler Judith , Walti Carla , Urwyler Sandrine Andrea , Schuetz Philipp , Christ-Crain Mirjam 
Published: September 2014

ObjectiveThe prognostic/diagnostic biomarker copeptin, an arginine vasopressin surrogate, reflects physical stress. Whether copeptin concentration increases upon psychological stress is unknown. We investigated psychological stress effects on copeptin secretion in healthy volunteers and patients with central diabetes insipidus (DI).DesignA prospective observational study was conducted to study the relation between copeptin concentration and psychological stress.MethodsA total of 20 healthy adults (ten female) and eight patients with central DI (four female) underwent the Trier Social Stress Test including, in order, 30-min waiting period, 10-min anticipation period, 10-min test period and 40-min recovery. Serum copeptin and cortisol concentrations and self-rated stress component feelings were determined in the pre-/post-anticipation period, post-test period and twice post-recovery.ResultsIn healthy volunteers, the median (25th–75th percentile) copeptin concentration peaked immediately during the post-test period at 5.1 (3.2–7.0) pmol/l, vs 3.7 (2.6–5.4) pmol/l at baseline. Over the measurement course, copeptin concentration significantly elevated (coefficient; 95% CI) (0.14; 0.06–0.23, P=0.002). The important predictors of increase in copeptin concentration were feelings of tension (0.06; 0.04–0.08, P<0.001) and avoidance (0.07; 0.04–0.10; P<0.001). Copeptin and cortisol levels were associated (0.43; 0.13–0.72, P<0.005). Patients with DI had lower baseline concentrations (1.55 (1.2–3.1) pmol/l) when compared with healthy volunteers, P=0.006. Patients with DI showed no increase upon psychological stress (peak 2.15 pmol/l (1.5–2.28), P=0.79). By contrast, cortisol values were similar in patients and volunteers.ConclusionsIn healthy volunteers, copeptin levels significantly increased after psychological stress testing; this response was blunted in patients with DI.
Die kartellrechtliche Bewertung des sog. kapitalmarktrechtlichen „cornering“
Authors: Thomas Stefan 
Published: September 2014

Zusammenfassung
Kapitalmarktrechtlich kann nach dem Verbot der Marktmanipulation des § 20a WpHG das sog. cornering problematisch sein. Darunter versteht man die Erlangung einer Kontrolle über das Angebot eines bestimmten Wertpapiers, etwa durch Erwerb einer Mehrheitsbeteiligung. Dies kann dem Mehrheitsaktionär in Verbindung mit bestimmten Erwartungen einzelner potentieller Aktienkäufer einen kurzfristigen Einfluss auf die Preisgestaltung des betreffenden Wertpapiers geben. In jüngerer Zeit ist die Frage aufgeworfen worden, ob ein solcher Tatbestand auch nach dem kartellrechtlichen Missbrauchsrecht verboten sein kann. Dem geht der vorliegende Beitrag nach.
Kartellrechtliche Überprüfung der Fortbildungssysteme von Berufskammern
Authors: Künstner Kim Manuel 
Published: September 2014

Zusammenfassung
Im Urteil vom 28. 2. 2013 (Rs C-1/12 – Ordem dos Técnicos Oficiais de Contas) führt der EuGH seine bisherige Rechtsprechung zur Qualifikation von Berufskammern als Unternehmensvereinigungen fort und erweitert sie in Nuancen. Der Gerichtshof stellt strenge Anforderungen an die Kartellrechtskonformität der Zulassung konkurrierender Drittanbieter durch Berufskammern, die selbst auch als Anbieter von Fortbildungsmaßnahmen aktiv sind. Aufgrund einer vergleichbaren Rolle der Landesärztekammern (LÄK) ist das Urteil auch hinsichtlich der zwingenden Fortbildung für Ärzte in Deutschland von Interesse. Die deutschen Ärztekammern haben insoweit bereits Erfahrungen mit dem Bundeskartellamt machen dürfen. Ein Streitpunkt im damaligen Verfahren war, ob es sich bei den Ärztekammern um Unternehmensvereinigungen im Sinne des Kartellrechts handelt. Insoweit gibt die EuGH-Entscheidung auch Anlass zu einer Neubewertung dieser Streitfrage.
An der schönen blauen Donau – Akteneinsicht in Kronzeugenanträge im Fluss
Authors: Hempel Rolf 
Published: September 2014

Zusammenfassung
Vor gut einem Jahr hat der Europäische Gerichtshof am 6. Juni 2013 über ein Vorabentscheidungsersuchen des OLG Wien in der Sache Bundeswettbewerbsbehörde gegen Donau Chemie AG u. a. entschieden. Jetzt, ein Jahr später, ist ein guter Zeitpunkt, noch einmal einen Blick auf die Entscheidung zu werfen. Die schöne, blaue Donau fließt unverändert durch Wien. Es ist zu prüfen, ob dies auch für den aktuellen Stand des Unionsrechts gilt, ob und wie sich das Recht nach Juni 2013 weiterentwickelt hat und was sich hieraus für die eine oder andere Frage ergibt, die sich im Zusammenhang mit der Entscheidung gestellt hatte.
Im Folgenden soll zunächst rekapituliert werden, was der Gerichtshof damals entschieden hatte (unter I). Zu der Entscheidung hatten sich – wie ausgeführt – einige Fragen ergeben, denen sodann nachzugehen ist (unter II bis VII). Zum Schluss ist ein kurzes Fazit zu ziehen (unter VIII).
ZnO Nanostructures on Electrospun Nanofibers by Atomic Layer Deposition/Hydrothermal Growth and Their Photocatalytic Activity
Authors: Kayaci Fatma , Vempati Sesha , Ozgit-Akgun Cagla , Biyikli Necmi , Uyar Tamer 
Published: September 2014

ABSTRACTA hierarchy of nanostructured-ZnO was fabricated on the electrospun nanofibers by atomic layer deposition (ALD) and hydrothermal growth, subsequently. Firstly, we produced poly(acrylonitrile) (PAN) nanofibers via electrospinning, then ALD process provided a highly uniform and conformal coating of polycrystalline ZnO with a precise control on the thickness (50 nm). In the last step, this ZnO coating depicting dominant oxygen vacancies and significant grain boundaries was used as a seed on which single crystalline ZnO nanoneedles (average diameter and length of ∼25 nm and ∼600 nm, respectively) with high optical quality were hydrothermally grown. The detailed morphological and structural studies were performed on the resulting nanofibers, and the photocatalytic activity (PCA) was tested with reference to the degradation of methylene blue. The results of PCA were discussed in conjunction with photoluminescence response. The nanoneedle structures supported the vectorial transport of photo-charge carriers, which is crucial for high catalytic activity. The enhanced PCA, structural stability and reusability of the PAN/ZnO nanoneedles indicated that this hierarchical structure is a potential candidate for waste water treatment.
REAQ-AODV: Route Stability and Energy Aware QoS Routing in Mobile Ad hoc Networks
Authors: Srinivasan P. , Kamalakkannan P. 
Published: September 2014

Frequent changes in network topology, confined battery capacity of nodes and unreliable nature of wireless channels are the main challenges for reliable routing in Mobile Ad hoc Network (MANET). Selecting a long lasting route is a critical task in MANET. In this paper, we propose a new protocol, Route Stability and Energy Aware Ad hoc On-demand Distance Vector (RSEA-AODV) protocol which is an enhancement of Ad hoc On-demand Distance Vector (AODV) protocol. It designs a bi-objective optimization formulation to compute the reliability factor based on stability and residual energy of nodes. The route with the highest reliability factor value is selected for data transmission. This protocol is compared with other similar routing protocols: PERRA and AODV. We use ns-2 for simulation. Our simulation results show that, the proposed protocol increases the node expiration time by 12 - 32 % and accomplishes 7 - 13 % higher packet delivery ratio compared to PERRA or AODV. The packet delay and control overhead of the proposed protocol is comparable to that of AODV.
A Improved EPC Class 1 Gen 2 Protocol with FCFS Feature in the Mobile RFID Systems
Authors: Li Xiaowu , Feng Quanyuan 
Published: September 2014

In all anti-collision protocols of RFID standards, EPCGlobal Class 1 Generation 2 (C1G2) protocol has been most widely used in RFID systems since it is simply, efficient and safety. Similar to most existing anti-collision protocols, The C1G2 protocol initially aims at tag identification of static scenarios, where all tags keep still during the tag identification process. However, in many real scenarios, tags generally move along a fixed path in the reader coverage area, which implies that tags stay the coverage area only for a limited time (sojourn time). The scenarios are usually called mobile RFID systems. Because the multiple tag identification based on a shared wireless channel is random, tags entering the reader coverage area earlier may be identified later (random later identification phenomenon). The phenomenon and the limited sojourn time may let some tags lost. In this paper, we propose an improved C1G2 protocol with first come first served feature in mobile RFID systems. The protocol can overcome the RLI phenomenon effectively and retains good initial qualities of C1G2 protocol by modifying it slightly. Simulation results show that the proposed protocol can significantly reduce the numbers of lost tags in mobile RFID systems. The idea of the paper is beneficial for redesigning other existing tag anti-collision protocols so as to make these protocols adapt to mobile RFID systems.